ClinicalTrials.gg
Sign In

Dysmenorrhea clinical trials

The registry lists 430 studies for Dysmenorrhea across more than 10 countries. 107 are recruiting or about to start. 342 of them are mainly about Dysmenorrhea (how this is decided). Per ClinicalTrials.gov, last updated 2026-11-10.

Get an email when these change. Save the Dysmenorrhea studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Watch these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your saved searches, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your saved searches. Stop any time.

Status

Completed
243
Recruiting
57
Status unknown
47
Not yet recruiting
45
Active, not recruiting
16
Terminated
11

Phase

Phase 3
50
Phase 2
36
Phase 4
23
Phase 1
13
Early Phase 1
6

Where

Turkey
81
United States
68
Egypt
36
Pakistan
28
Spain
23
China
21

Who runs them

Cairo University (32) · Riphah International University (21) · Bayer (11) · AbbVie (7) · Nobelpharma (6) · Organon and Co (5) · Endeavor Health (4) · Ankara Yildirim Beyazıt University (4)

What is being tested here

Drugs under test in Dysmenorrhea studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted

DrugOpenPhase 3All
Elagolix179
Naproxen126
Norethindrone145
Acetaminophen104
Norethindrone Acetate123
Desloratadine101
Magnesium Sulfate101
Propolis101
Linzagolix045
Relugolix033

Drug classes tested here NSAIDs 1 open · Hormonal contraceptives 1 open · COX-2 inhibitors 5 · Estrogens 4

Coming up

4phase 3 studies under way
29studies finish main data collection within a year2 of them phase 3

Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.

The 10 nearest, phase 3 first

Who these studies take

Of the 57 Dysmenorrhea studies recruiting now, 7 (12%) set no upper age limit and 49 (86%) stop at 75 or younger. 11 (19%) take children under 18. 56 (98%) are for women only and 0 (0%) for men only; 20 (35%) take healthy volunteers.

Recruiting studies that take each age, of 57
AgeWomenMen
102 (4%)0 (0%)
1848 (84%)1 (2%)
3040 (70%)1 (2%)
4027 (47%)1 (2%)
5016 (28%)1 (2%)
659 (16%)1 (2%)
758 (14%)1 (2%)
858 (14%)1 (2%)

Across all 430 studies, recruiting or not: 84% stop at 75 or younger and 84% at 65; 22% take children; 98% are for women only and 0% for men only; 36% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.

How long Dysmenorrhea studies take

Of 17 phase 3 interventional studies under Dysmenorrhea, half reached primary completion within 28 months of starting, counting those still running.

Start to primary completionEvery sponsorIndustryNon-industry
Phase 328 mo19–30 · 17 studies——
Interventional, no phase8 mo3–16 · 188 studies—8 mo4–16 · 178 studies
Observational23 mo4–47 · 22 studies——

Each figure is the month by which half the studies had reached primary completion, with the range in which the middle half did. Studies still running count until their last registry update; studies that stopped early are left out. Phase 1 includes early phase 1; observational means prospective or not stated, as retrospective and cross-sectional studies date a window of data rather than a study. How these figures are worked out

What changed recently

From the registry's own updates since Oct 13, 2026.

Started recruiting1

Newly registered5

Studies

Recruiting first, then most recently updated. Showing 50 of 430. Browse all 430 → or search them.